Reading an interaction checker output critically posts 31–60

I came in to disagree and I am leaving without a disagreement.

Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.

That is the version I would defend. It is not the version I started with.

Narrowing post #46, because the general version has more than one answer.

The version of reading an interaction checker output that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those conditions are where the interesting cases live.

Everything in post #44 holds. The case it does not cover is the one I have.

SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.

I have no financial interest in anything named in this thread and I want to say so before I comment on reading an interaction checker output, because it is the sort of subject where it matters.

Post #48 put the caveat in the right place and I want to underline it.

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

Where the reading an interaction checker output reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.

Adding a null result on reading an interaction checker output. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.

Everything in post #51 holds. The case it does not cover is the one I have.

Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as one.

Seconded. It reads as careful rather than confident, which is the right register.

A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is usually worse rather than better.

The interesting part of this is the exception, and I do not understand the exception.

The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather than filling the gap.

Worth one more sentence than it usually gets.

Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here.

A modest claim, modestly supported.

The arithmetic in post #55 is right; the assumption feeding it is the part to check.

Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about rate and timing rather than about the total absorbed, in most published cases.

Written from notes rather than memory, which is why the numbers are specific.

I had written a reply contradicting post #55 and deleted it. Here is what survived.

A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not have.

Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer.